JCM, Vol. 14, Pages 8209: Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease
JCM, Vol. 14, Pages 8209: Real-World Effectiveness of Finerenone Added to SGLT2 Inhibitor and GLP-1 Receptor Agonist Therapy in Individuals with Type 2 Diabetes and Chronic Kidney Disease Journal of Clinical Medicine doi: 10.3390/jcm14228209 Authors: Afif Nakhleh Khaled Khazim Naim Shehadeh Background/Objectives: Recent randomized controlled trial evidence in adults with type 2 diabetes (T2D) and […]
Novo Nordisk Rolls Out Lower Prices for Ozempic and Wegovy
WEDNESDAY, Nov. 19, 2025 — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
The company announced that through the end of March…
The Ozempic era should change how we think about self-control
Struggling to manage weight can seem like a failure of raw willpower. GLP-1 drugs highlight how misguided that view is – by Matthew C Haug Read on Psyche
Pandemic & Plagues Update – November 19, 2025
COVID-19: “As of November 11, 2025, we estimate that COVID-19 infections are growing or likely growing in 20 states, declining or likely declining in 9 states, and not changing in 18 states.” Source: www.cdc.gov/cfa-modeling… [image or embed] — Denis – The COVID Info Guy (@thecovidinfoguy.bsky.social) November 15, 2025 at 12:53 AM === The Director-General of […]
The Zacks Analyst Blog Highlights Microsoft, Amazon.com and Eli Lilly
For Immediate Release Chicago, IL – November 19, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft Corp. MSFT, Amazon.com, Inc. AMZN and Eli […]
STAT+: Can GLP-1 drugs treat Alzheimer’s? Novo Nordisk will soon announce key results
Within the next two weeks, Novo Nordisk is expected to announce the results of perhaps the most ambitious studies yet of its blockbuster GLP-1 drug semaglutide — whether the medicine can help slow the progression of Alzheimer’s disease. The Danish company has repeatedly stressed that these are risky studies, since there hasn’t yet been definitive […]
Why alcohol may hit harder for people on GLP-1 drugs like Ozempic, Wegovy
A Yale study suggests GLP-1 drugs like semaglutide slow alcohol breakdown in the liver, raising blood alcohol levels even as they reduce toxic byproducts linked to inflammation and liver damage
Patient-Reported Skin Changes After GLP-1 Use Explored
The results of a patient survey ‘reinforce the importance of dermatology in obesity care,’ according to one of the authors. Medscape Medical News
Can weight-loss drugs like Ozempic help reduce alcohol and drug cravings?
Research suggests GLP-1 injections like Ozempic and Zepbound may dampen alcohol and drug cravings by lowering dopamine reward responses, but larger human trials are still underway
Biomolecules, Vol. 15, Pages 1622: Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis
Biomolecules, Vol. 15, Pages 1622: Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis Biomolecules doi: 10.3390/biom15111622 Authors: Pao-Yen Lin Bing-Yan Zeng Chih-Wei Hsu Mein-Woei Suen Chao-Ming Hung Brendon Stubbs Yen-Wen Chen Tien-Yu Chen Wei-Te Lei Jiann-Jy Chen Bing-Syuan Zeng Kuan-Pin Su Chih-Sung Liang […]